Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
| FDA Review Backs Vytorin in Kidney Disease Patients - MedPage Today |
|
|
|
MedPage Today The review also highlighted the greater benefit of the combination in patients not yet on dialysis, with a risk ratio for the primary outcome of 0.77 (95% CI 0.67 to 0.88) versus 0.94 (not significant) among dialysis patients. ... FDA backs Merck cholesterol drug to lower heart problems in kidney disease |
Professional dialysis recruitment

